Prostate Cancer Canada

What We're Funding

For more information visit
www.movember.com

In The News

Media Advisory - Prostate Cancer Canada celebrates local Vancouver Hero
Vancouver, British Colombia, April 16 –– Prostate Cancer Canada will honour the late Jack Poole, former VANOC Board Chair and local businessman, with the Local Hero Award. Jack was a generous benefactor to the Vancouver General Hospital and UBC Hospital Foundation with gifts totalling $3 Million for “Jack the Robot”, a da Vinci S HD surgical system, and a $1 Million gift towards the Robert H. N. Ho Research Centre. His lead donation attracted a further $3.5 million in donations including $1.5 million from Jimmy Pattison. Together these donations enabled VGH to become the fourth Canadian hospital to employ robotic technology in surgery.

Media Advisory- Prostate Cancer Canada celebrates local Calgary Hero
Calgary, AB, April 10 –– Local Hero Dr. Jay Lee will be honoured on April 11th at the annual Wake Up Call Breakfast, hosted by Prostate Cancer Canada, in partnership with the Prostate Cancer Centre. Dr. Lee is being recognized for his extraordinary contribution to the fight against prostate cancer.

Click For Information Archive

Upcoming Programs

Two programs that are in development for launch in early 2013 represent unique opportunities for research in areas identified as in need of further study.

Targeted Request for Applications

This new initiative will allow emerging priorities and opportunities to be addressed. Programs will be launched that will answer specific identified questions in prostate cancer that may be in areas such as prevention, imaging, survivorship, biomarkers, etc. The focus of the new targeted programs will be recommended by the Research Advisory Council following consultation with key members of the prostate cancer research community in Canada.

Clinical Trials Initiative

A brand new program, the Clinical Trials Initiative will support academic clinical trials by utilizing existing clinical trial infrastructure and building in a correlative science component, while also leveraging partnerships. The precise mechanism to support clinical trials will be recommended by PCC’s Research Advisory Council following further consultation with experts in this field. It will be a unique opportunity likely to have a global impact for prostate cancer research and survivorship.